(Bloomberg) Drugmakers with patents being challenged by Kyle Bass are striking back, accusing the hedge-fund manager of abusing a government review process designed to weed out useless patents and demanding his petitions be tossed.
Drugmakers Strike Back: Kyle Bass Blasted Over Patient Challenges
This entry was posted in Syndicated. Bookmark the permalink.
